SCHEMBL4460422

SCHEMBL4460422

CSNC(=O)N/N=C(\CCN(C)C)c1ccc(-c2cccc(Cl)c2)o1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
S1PR4 O95977 1/20 0.44
SLC9A1 P19634 1/20 0.44
ALDH1A1 P00352 6/20 0.44
RAB9A P51151 3/20 0.44
HPGD P15428 3/20 0.42
MAPT P10636 3/20 0.42
SMN1; SMN2 Q16637 3/20 0.41
NPC1 O15118 2/20 0.41
LMNA P02545 2/20 0.41
THRB P10828 1/20 0.41
MAPK1 P28482 1/20 0.41
PDE4B Q07343 3/20 0.40
KDM4E B2RXH2 3/20 0.40
MGAM O43451 2/20 0.40
GAA P10253 2/20 0.40
SI P14410 2/20 0.40
MGAM2 Q2M2H8 2/20 0.40
CYP1A2 P05177 1/20 0.40
CYP3A4 P08684 1/20 0.40
CYP2C9 P11712 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13611608 0.81 MAPT (0.44) S1PR4SLC9A1ALDH1A1RAB9AHPGD
SCHEMBL4460430 0.81 MAPT (0.44) S1PR4SLC9A1ALDH1A1RAB9AHPGD
SCHEMBL1218954 0.78 SLC9A1 (0.53) S1PR4SLC9A1ALDH1A1RAB9AHPGD
SCHEMBL4323041 0.75 ALDH1A1 (0.45) S1PR4ALDH1A1RAB9AHPGDMAPT
SCHEMBL4323030 0.75 ALDH1A1 (0.45) S1PR4ALDH1A1RAB9AHPGDMAPT
SCHEMBL4460428 0.74 SLC9A1 (0.47) S1PR4SLC9A1ALDH1A1RAB9AHPGD
SCHEMBL4335881 0.73 ALDH1A1 (0.46) ALDH1A1RAB9AHPGDMAPTSMN1; SMN2
SCHEMBL4335875 0.73 ALDH1A1 (0.46) ALDH1A1RAB9AHPGDMAPTSMN1; SMN2
SCHEMBL4338967 0.73 HTT (0.50) ALDH1A1RAB9AHPGDMAPTSMN1; SMN2
SCHEMBL4338981 0.73 HTT (0.50) ALDH1A1RAB9AHPGDMAPTSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7521062-B2 Thiosemicarbazones as anti-virals and immunopotentiators NOVARTIS VACCINES & DIAGNOSTICS, INC. (US) 2009-04-21 US disclosed